Fauna Bio is developing new ways to treat human diseases, such as heart disease and neurodegenerative disease, by adopting mechanisms animals have developed for traits such as hibernation and deep-diving. Founded by three scientists who have intimate knowledge of the best science and resources from the field of non-model organisms, Fauna Bio leverages data from hundreds of species in order to help develop pre-clinical and early clinical testing for new therapeutics targeting human diseases.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 04/11/19 | $4,100,000 | Seed |
Beagle Ventures Boom Capital Longevity Fund Pacific 8 Ventures True Ventures  | undisclosed |
| 09/21/21 | $9,000,000 | Seed |
Arcadia Science BioMed Ventures Boom Capital LifeForce Capital Pacific 8 Ventures True Ventures Vibe Capital | undisclosed |
